Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Genor Biopharma Holdings (6998 HK)
Watchlist
42
Analysis
Health Care
•
China
Genor Biopharma Holdings Ltd operates as a biopharmaceutical company. The Company focuses on developing and commercializing oncology and autoimmune drugs. Genor Biopharma Holdings serves customers worldwide.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Genor Biopharma Holdings
•
13 Oct 2024 09:54
China Healthcare Weekly (Oct.13)-Genor to Acquire Edding, RemeGen's Bleak Outlook, Zai Lab's Trouble
Genor/Edding are merging through a reverse takeover, but valuation is unsatisfactory. Remegen is negative example among China Biotech.Weak...
Xinyao (Criss) Wang
Follow
502 Views
Share
bearish
•
Elpiscience Biopharmaceuticals
•
22 Jul 2024 08:55
Pre-IPO Elpiscience Biopharmaceuticals - Will Investors Still Buy in These Stories?
Elpiscience's strong capital operation capabilities are no longer enough as investors shift focus to cash flow and drug sales revenue. We have...
Xinyao (Criss) Wang
Follow
264 Views
Share
bearish
•
Hua Medicine Ltd
•
25 Jun 2023 09:29
China Healthcare Weekly (Jun.23) - National TCM VBP Results, CDE Changes Game Rule, Hua Medicine
Results of National TCM VBP were released, involving some big varieties. CDE changes game rule on drug approva. Companies has to change clinical...
Xinyao (Criss) Wang
Follow
398 Views
Share
bearish
•
Thematic (Sector/Industry)
•
13 Mar 2023 08:30
“Sudden Death” of Silicon Valley Bank (SVB) - The Impact on China Healthcare
SVB's "sudden death" would affect Chinese healthcare companies. Investors need to reassess the risks of related companies.We don't think SVB’s woes...
Xinyao (Criss) Wang
Follow
470 Views
Share
bearish
•
Shandong BoAn Biotechnology
•
20 Dec 2022 10:00
Pre-IPO Shandong Boan Biotechnology - Conservative About the Outlook
Due to lack of differentiated/frontier enough target layout and slow progress, Boan's product commercialization potential is highly uncertain....
Xinyao (Criss) Wang
Follow
498 Views
Share
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.39.3
x